1. Home
  2. PGP vs RGC Comparison

PGP vs RGC Comparison

Compare PGP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Global StocksPlus & Income Fund of Beneficial Interest

PGP

Pimco Global StocksPlus & Income Fund of Beneficial Interest

HOLD

Current Price

$9.03

Market Cap

102.9M

Sector

Finance

ML Signal

HOLD

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$21.00

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGP
RGC
Founded
2003
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Finance Companies
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.9M
9.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PGP
RGC
Price
$9.03
$21.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.8K
298.0K
Earning Date
01-01-0001
10-24-2025
Dividend Yield
10.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.83
$0.09
52 Week High
$7.81
$83.60

Technical Indicators

Market Signals
Indicator
PGP
RGC
Relative Strength Index (RSI) 65.99 61.10
Support Level $8.52 $16.30
Resistance Level $8.91 $26.42
Average True Range (ATR) 0.11 2.04
MACD 0.01 0.75
Stochastic Oscillator 89.62 49.32

Price Performance

Historical Comparison
PGP
RGC

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: